Atrion Corp. (ATRI) Announces $1.05 Quarterly Dividend
Atrion Corp. (NASDAQ:ATRI) announced a quarterly dividend on Friday, November 11th. Stockholders of record on Thursday, December 1st will be paid a dividend of 1.05 per share on Thursday, December 15th. This represents a $4.20 annualized dividend and a dividend yield of 0.86%. The ex-dividend date is Tuesday, November 29th.
Shares of Atrion Corp. (NASDAQ:ATRI) opened at 491.00 on Thursday. The stock has a market cap of $895.58 million, a price-to-earnings ratio of 32.45 and a beta of 0.81. The stock’s 50 day moving average price is $442.94 and its 200 day moving average price is $434.94. Atrion Corp. has a one year low of $350.00 and a one year high of $493.00.
In other news, Chairman Emile A. Battat sold 1,102 shares of Atrion Corp. stock in a transaction that occurred on Thursday, November 10th. The shares were sold at an average price of $443.01, for a total transaction of $488,197.02. Following the sale, the chairman now owns 142,968 shares of the company’s stock, valued at approximately $63,336,253.68. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Hugh J. Morgan, Jr. sold 2,021 shares of Atrion Corp. stock in a transaction that occurred on Monday, August 29th. The shares were sold at an average price of $441.11, for a total transaction of $891,483.31. Following the sale, the director now directly owns 19,942 shares in the company, valued at approximately $8,796,615.62. The disclosure for this sale can be found here. Insiders own 24.23% of the company’s stock.
About Atrion Corp.
Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.
Receive News & Stock Ratings for Atrion Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion Corp. and related stocks with our FREE daily email newsletter.